在线报刊亭
Pharmaceuticals and Healthcare Reports Japan Dyslipidemia Market 点击阅读
  • 评论

Pharmaceuticals and Healthcare Reports

Japan Dyslipidemia Market

出版日期 / “健康与健身, 健康与健身” / 语言—English / 3页
The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward. 更多
显示标签
标签: japan dyslipidemia market analysis
下载
免费订阅

“ Pharmaceuticals and Healthcare Reports”的其他出版物

查看所有出版物

相关的杂志